The Patient-Centered Outcomes Research Institute (PCORI) announced the approval of funding totaling $14.4 million for UNC researcher to study new treatment options for pediatric inflammatory bowel diseases (PIBD). Michael D. Kappelman, MD, MPH, professor of pediatrics and epidemiology at the UNC School of Medicine, will serve as principal investigator.
